TET, Pharmasset Settle Spat Over Gene Test Patent

Law360, New York (August 14, 2009, 5:18 PM EDT) -- TET Systems Holding GmbH & Co. KG and Pharmasset Inc., which develops treatments for viral infections, have reached a deal in TET Systems' infringement suit over a patent related to technology that controls gene expression and can be used to test new drug compounds.

Germany-based TET Systems filed a stipulated motion for dismissal of all claims, counterclaims and defenses Thursday in the U.S. District Court for the District of New Jersey, saying that both parties had agreed to dismiss the case with prejudice and pay their...
To view the full article, register now.